Shahram Salek-Ardakani - Chief Scientific Officer at Janux Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
JANX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Shahram Salek-Ardakani since 12/22/2023

Holdings reported by Shahram Salek-Ardakani for Janux Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 114K Jan 3, 2022 Direct Common Stock

Transactions reported by Shahram Salek-Ardakani for Janux Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.